{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:49:39Z","timestamp":1789066179704,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is a monogenic, phenotypically highly variable disease with multisystem pathology. The phenotypic heterogeneity of SCD is attributed to environmental and genetic factors such as fetal hemoglobin and co-inheritance of \u03b1-thalassemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To look for different types of \u03b1-thalassemia gene mutations among SCD patients and evaluate the influence of the co-inheritance of \u03b1-thalassemia on clinical and hematological variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional analytical study included 765 SCD patients, and 150 patients (with low mean corpuscular volume (MCV), low mean corpuscular hemoglobin (MCH) and normal serum ferritin levels) were tested for \u03b1-thalassemia gene mutations. Multiplex PCR and reverse hybridization and sequencing for both \u03b1 genes using the Vienna Lab Strip Assay PCR study were performed using conventional PCR technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 150 patients tested for \u03b1-thalassemia gene mutations, 141 patients were found to have one or more of the mutational types, representing 18.4% of all studied SCD patients. The most common mutations found were the -\n                      <jats:sup>3.7<\/jats:sup>\n                      deletion (76.6%), followed by the -\n                      <jats:sup>4.2<\/jats:sup>\n                      deletion (12.1%), mutant \u03b12\n                      <jats:sup>polyA-1<\/jats:sup>\n                      (Saudi type) (9.2%), and --\n                      <jats:sup>MED<\/jats:sup>\n                      double gene deletion (7.8%). Acute painful episodes did not differ significantly in sickle cell anemia (SCA) patients with or without \u03b1-thalassemia, although the co-inheritance of \u03b1-thalassemia has a protective role against many disease-related complications. However, this role was not observed with other types of SCD. The means of red blood cell count, hemoglobin, and hematocrit were significantly higher, while the MCV, MCH, reticulocyte count, and hemoglobin A2 percentage were significantly lower in patients with \u03b1-thalassemia gene mutations than in those without \u03b1-thalassemia gene mutations (P &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The co-inheritance of \u03b1-thalassemia and SCA confers protection against many disease-related complications and is associated with improved hematological indices. However, this protection was not noticed in patients with other types of SCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_11_20","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T01:48:22Z","timestamp":1623462502000},"page":"874-882","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Co-Inheritance of \u03b1-Thalassemia Gene Mutation in Patients with Sickle Cell Disease"],"prefix":"10.4103","volume":"24","author":[{"given":"ZA","family":"Ali Al-Barazanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SS","family":"Abdulateef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaad Kadhum","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20240907","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2013-303773","article-title":"Sickle cell disease: A neglected chronic disease of increasing global health importance","volume":"100","author":"Chakravorty","year":"2015","journal-title":"Arch Dis Child"},{"key":"R2-14-20240907","doi-asserted-by":"crossref","first-page":"021103","DOI":"10.7189\/jogh.08.021103","article-title":"The global burden of sickle cell disease in children under five years of age: A systematic review and meta-analysis","volume":"8","author":"Wastnedge","year":"2018","journal-title":"J Global Health"},{"key":"R3-14-20240907","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: Modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"R4-14-20240907","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5581\/1516-8484.20120041","article-title":"Sickle cell disease: Looking back but towards the future","volume":"34","author":"Can\u00e7ado","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R5-14-20240907","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"R6-14-20240907","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1535370216640385","article-title":"Clinical severity in sickle cell disease: The challenges of definition and prognostication","volume":"241","author":"Quinn","year":"2016","journal-title":"Exp Biol Med"},{"key":"R7-14-20240907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e3283420fd0","article-title":"Update on fetal hemoglobin gene regulation in hemoglobinopathies","volume":"23","author":"Bauer","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"R8-14-20240907","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"Am J Hematol"},{"key":"R9-14-20240907","doi-asserted-by":"crossref","first-page":"e27934","DOI":"10.1002\/pbc.27934","article-title":"Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia","volume":"66","author":"Tall","year":"2019","journal-title":"Ped Blood Cancer"},{"key":"R10-14-20240907","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/ejh.13173","article-title":"Rheological properties of sickle erythrocytes in patients with sickle cell anaemia: The effect of hydroxyurea, fetal hemoglobin and \u03b1-thalassaemia","volume":"101","author":"Ballas","year":"2018","journal-title":"Eur J Haematol"},{"key":"R12-14-20240907","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bjhh.2014.06.002","article-title":"Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia","volume":"36","author":"Camilo-Ara\u00fajo","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R13-14-20240907","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1590\/S1415-47572008000400003","article-title":"Clinical and molecular characteristics of sickle cell anemia in the northeast of Brazil","volume":"31","author":"Adorno","year":"2008","journal-title":"Genet Mol Biol"},{"key":"R14-14-20240907","doi-asserted-by":"crossref","first-page":"e22656","DOI":"10.1002\/jcla.22656","article-title":"Albuquerque DM, Adekile A, Costa FF. Influence of alpha thalassemia on clinical and laboratory parameters among Nigerian children with sickle cell anemia","volume":"33","author":"Olatunya","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"R15-14-20240907","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjh.15011","article-title":"Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon","volume":"180","author":"Wonkam","year":"2018","journal-title":"Br J Haematol"},{"key":"R16-14-20240907","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcmd.2013.01.012","article-title":"Spectrum of \u03b1-thalassemia mutations including first observation of--FIL deletion in Hatay Province, Turkey","volume":"51","author":"Celik","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"R17-14-20240907","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/03630269.2012.692344","article-title":"Sickle cell disease in the Kurdish population of Northern Iraq","volume":"36","author":"Al-Allawi","year":"2012","journal-title":"Hemoglobin"},{"key":"R20-14-20240907","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ejhg.2014.131","article-title":"EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies","volume":"23","author":"Traeger-Synodinos","year":"2015","journal-title":"Eur J Human Genet"},{"key":"R22-14-20240907","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2009.08054.x","article-title":"Significant haemoglobinopathies: Guidelines for screening and diagnosis","volume":"149","author":"Ryan","year":"2010","journal-title":"Br J Haematol"},{"key":"R23-14-20240907","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13312-012-0217-z","article-title":"Sickle cell anemia from Central India: A retrospective analysis","volume":"49","author":"Jain","year":"2012","journal-title":"Indian Pediatrics"},{"key":"R24-14-20240907","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.bbmt.2009.10.001","article-title":"Severe sickle cell disease-pathophysiology and therapy","volume":"16","author":"Buchanan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R27-14-20240907","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bmj.39238.399444.55","article-title":"Body mass index cut offs to define thinness in children and adolescents: International survey","volume":"335","author":"Cole","year":"2007","journal-title":"BMJ"},{"key":"R28-14-20240907","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"R31-14-20240907","doi-asserted-by":"crossref","first-page":"45","DOI":"10.26719\/2003.9.1-2.45","article-title":"Frequency of hemoglopinopathies and glucose 6 phosphate dehydrogenase in Basra","volume":"9","author":"Hassan","year":"2003","journal-title":"East Mediterr Health J"},{"key":"R32-14-20240907","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21572","article-title":"Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study","volume":"85","author":"Sebastiani","year":"2010","journal-title":"Am J Hematol"},{"key":"R33-14-20240907","doi-asserted-by":"crossref","first-page":"e0197927","DOI":"10.1371\/journal.pone.0197927","article-title":"A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell Anaemia","volume":"13","author":"Adeyemo","year":"2018","journal-title":"PLoS One"},{"key":"R34-14-20240907","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2141.2008.07084.x","article-title":"Genetic modifiers of the beta-haemoglobinopathies","volume":"141","author":"Thein","year":"2008","journal-title":"Br J Haematol"},{"key":"R35-14-20240907","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcmd.2017.09.004","article-title":"Molecular basis of \u03b1-thalassemia","volume":"70","author":"Farashi","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"R36-14-20240907","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-5-13","article-title":"\u03b1 thalassaemia","volume":"5","author":"Harteveld","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R37-14-20240907","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/03630269.2012.749490","article-title":"The spectrum \u03b1- thalassemia mutations in the Kurdish population of Northeastern Iraq","volume":"37","author":"Al-Allawi","year":"2013","journal-title":"Hemoglobin"},{"key":"R38-14-20240907","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000203753","article-title":"Morbidity, \u03b2S haplotype and \u03b1-globin gene patterns among sickle cell anemia patients in Kuwait","volume":"96","author":"Adekile","year":"1996","journal-title":"Acta Haematol"},{"key":"R39-14-20240907","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ijlh.12577","article-title":"Frequencies and phenotypic consequences of association of \u03b1- and \u03b2 -thalassemia alleles with sickle-cell disease in Bahrain","volume":"39","author":"Abuamer","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"R40-14-20240907","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejmg.2014.09.005","article-title":"Sickle cell anemia and a-thalassemia: A modulating factor in homozygous Hb S\/S patients in Oman","volume":"57","author":"Hassan","year":"2014","journal-title":"Eur J Med Genet"},{"key":"R41-14-20240907","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5045\/kjh.2011.46.3.192","article-title":"Genotypic influence of \u03b1-deletions on the phenotype of Indian sickle cell anemia patients","volume":"46","author":"Pandey","year":"2011","journal-title":"Korean J Hematol"},{"key":"R42-14-20240907","first-page":"768","article-title":"Prevalence of thalassaemia mutations in sickle cell disease population of Madhya Pradesh, Central India","volume":"5","author":"Singh","year":"2016","journal-title":"Int J Curr Microbiol App Sci"},{"key":"R43-14-20240907","doi-asserted-by":"crossref","first-page":"e100516","DOI":"10.1371\/journal.pone.0100516","article-title":"The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival","volume":"9","author":"Rumaney","year":"2014","journal-title":"PLoS One"},{"key":"R45-14-20240907","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2017.06.004","article-title":"Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors","volume":"70","author":"Serjeant","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"R46-14-20240907","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","article-title":"Genetic etiologies for phenotypic diversity in sickle cell anemia","volume":"9","author":"Steinberg","year":"2009","journal-title":"ScientificWorldJournal"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_11_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:16:49Z","timestamp":1787843809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_11_20"}},"subtitle":["Impact on Clinical and Hematological Variables"],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_11_20","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}